Watch this page throughout the day for updates on COVID-19 in Calgary
Article content
COVID vaccine makers shift focus to boosters
In the coming year, most COVID vaccinations will be booster shots, or first inoculations for children, which are still gaining regulatory approvals around the world, they said.
Pfizer, which makes its shot with Germany’s BioNTech SE, and Moderna still see a major role for themselves in the vaccine market even as overall demand declines.
Upstart U.S. vaccine maker Novavax Inc and Germany’s CureVac NV, which is working with GlaxoSmithKline, are developing vaccines they hope to target at the booster market.
The roles of AstraZeneca Plc and Johnson & Johnson, whose shots have been less popular or effective, are expected to decline in this market.
‘Like a prison’: Shanghai, Beijing ratchet up COVID curbs
Article content
China’s two largest cities tightened COVID-19 curbs on Monday, fueling public angst and even questions about the legality of its uncompromising battle with the virus that has battered the world’s second-largest economy.
In Shanghai, enduring its sixth week of lockdown, authorities have launched a new push to end infections outside quarantine zones by late May, according to people familiar with the matter.
While there has been no official announcement, residents in at least four of Shanghai’s 16 districts received notices at the weekend saying they would not be allowed to leave their homes or receive deliveries, prompting a scramble to stock up on food.
Some of these people had previously been allowed to move around their residential compounds.
“Go home, go home!” a woman shouted through a megaphone at residents mingling below an apartment block impacted by the new restrictions on Sunday, a scene that might baffle the rest of the world that has opted to open up and live with the virus.